Prexton Therapeutics prextontherapeutics.com


Public lists: Pharma Startups (4732)

Prexton Therapeutics is a biopharmaceutical company which applies a new scientific approach that fully integrates molecular, behavioral and chemistry technologies to address Parkinson's disease and other brain disorders. The company uses its discovery platform to target specific novel compounds focused on the treatment of Parkinson's disease.

Prexton Therapeutics is a biopharmaceutical company which applies a new scientific approach that fully integrates molecular, behavioral and chemistry technologies to address Parkinson's disease and other brain disorders. The company uses its discover...Show all

Company (Acquired)

Phone: +41 22 706 90 10

Fax:

14 chemin des Aulx

Geneva, CH-1228
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Prexton Therapeutics $43.4M Mar 16, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Prexton Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Seroba Life SciencesVenture CapitalDublin, IrelandSeries B
Forbion Capital PartnersVenture CapitalNaarden, NetherlandsSeries B
Merck VenturesCorporate VentureAmsterdam, NetherlandsSeries B, Series A, Seed VC
Sunstone CapitalVenture CapitalCopenhagen, DenmarkSeries B, Series A
Ysios Capital PartnersVenture CapitalBarcelona, SpainSeries B, Series A
See all 5 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Novel chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptors Aug 27, 2015 Application